1 / 14

Presented by: Allison Anguren and Priya Vasudeva

Presented by: Allison Anguren and Priya Vasudeva. Introduction. Metabolomics the quantitative measurement of the dynamic metabolics response of living systems to pathophysiological stimuli, environmental modulation, or genetic modifications

zinnia
Download Presentation

Presented by: Allison Anguren and Priya Vasudeva

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Presented by: Allison Anguren and Priya Vasudeva

  2. Introduction • Metabolomics • the quantitative measurement of the dynamic metabolics response of living systems to pathophysiological stimuli, environmental modulation, or genetic modifications • Monitoring of small molecule concentrations can provide information about disease progression or treatment response • Cancer cells have a number of specific metabolic features • Ex) Warburg effect

  3. Introduction • Agents that promote apoptosis are powerful tools for cancer therapeutics • Detection and monitoring of early apoptosis biomarkers are urgently needed in clinical trials • Monitoring apoptosis is challenging

  4. Aim of the study: • To design fast, robust, reliable, and affordable method of measuring metabolites in cells • To find early biomarkers of apoptosis in cancer cell lines

  5. Methods • Human cancer cell lines • HEK 293, HepG2, PC3, MCF7 • MTT Assay • Caspase 3/7 assay

  6. Methods • NBS Assay • Newborn Screening assay detect levels of 42 amino acids • Tandem Mass Spectrometry • Quantified the amount of 42 amino acids and acylcarnitines

  7. Results-MTT Assay • Tested the viability of cell lines to treatments of staurosporine and heating. • Decreased viability after 24hrs of staurosporine treatment.

  8. Results-Apoptosis Validation • Caspase 3 and 7 activity were analyzed to assess induced apoptosis. • Treatment with 4um of staurosporine had greater effect.

  9. Results-Metabolic Signatures • Used NBS to detect metabolites. • Analyzed 42 amino acids by and acylcarnitines by MS/MS • Differences in the concentrations of metabolites in various cell lines.

  10. Results-Table 1

  11. Results-Table 2 • In HEK 293, HepG2, and PC3, Asp, Glu, Met, Gly, Ala, C3-carnitine, and C3DC-carnitine up regulated in apoptotic vs necrotic cells • MCF7 cells display very different metabolic signature

  12. Conclusions • Used metabolics as markers of genomic changes due to apoptotic processes • Discriminated between necrosis and apoptosis by metabolics signatures • NBS and MS/MS can be used for high-throughput quantification of metabolites. • Distinct changes in Asp, Glu, Met, Ala, Gly, C3-carnitine, and C3DC-carnitine.

  13. Big Picture • Able to use targeted metabolics to assay a known group of molecules • Use metabolic signatures to test the efficiency of agents causing apoptosis • Can monitor apoptosis metabolic biomarkers in cancer therapeutics and anticancer therapies. • Cons: Can only detect known metabolites

More Related